Source: PR Newswire

Press Release: Recombinetics : Makana Therapeutics Awarded KidneyX Artificial Kidney Prize for Innovation in Xenotransplantation

EAGAN, Minn., Sept. 15, 2021 /PRNewswire/ -- Makana Therapeutics today received a $650,000 KidneyX Artificial Kidney Prize for their work to increase the supply of kidney donor organs through pig-to-human xenotransplants. Xenotransplantation is the process of transplanting organs or...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Rocco Morelli's photo - Interim-CEO of Recombinetics

Interim-CEO

Rocco Morelli

CEO Approval Rating

82/100

Read more